Skip to content

Bromhexine

Bromhexine hydrochloride is a mucolytic: it thins and loosens mucus to help clear chest congestion. The catalogue represents it once as an 8 mg single-ingredient tablet and once inside Bro-zedex, a cough syrup with three additional active ingredients.

Bromhexine Tablets

Productive Respiratory Tract Disease

8mg

Formulated to alleviate viscid respiratory secretions to support mucus expectoration and target airway clearance.

From$1.36/ tabletView

Bro-zedex Syrup

Productive Cough, Bronchial Asthma

100ml

Indicated to address respiratory congestion to relieve thick mucus and support clear bronchial airways.

From$25.00/ bottleView

Key points

  • Bromhexine is used to make thick airway mucus easier to clear.
  • Eight-milligram immediate-release tablets are an established form.
  • Bro-zedex also contains terbutaline, guaifenesin and menthol.
  • Bromhexine has a small recognised risk of severe allergic and skin reactions.

The 8 mg tablet record

Bromhexine Tablets contains bromhexine alone at 8 mg. Australian regulator guidance identifies 8 mg immediate-release tablets as a standard form and describes the ingredient’s mucolytic role in chest congestion. The record sits in respiratory health.

What the syrup record contains

Bro-zedex Syrup is a four-ingredient product. In addition to bromhexine, its catalogue identity lists terbutaline, guaifenesin and menthol. The stated 100 ml describes the bottle volume, not a bromhexine concentration. Its attached health topics include productive cough and chronic obstructive pulmonary disease.

European regulatory review describes bromhexine medicines as single products or fixed combinations. It also records a small risk of severe allergic reactions and severe cutaneous adverse reactions. A progressive rash, swelling or other signs of a serious reaction call for prompt medical assessment.

Further reading